Eagle Pharmaceuticals Announces Amendment to Limited Duration Stockholder Rights Plan
Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its Board of Directors (the “Board”) has approved an amendment to its previously disclosed limited duration ...
Autolus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
In December 2024, the National Comprehensive Cancer Network® (NCCN) added AUCATZYL (obecabtagene autoleucel) to its Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for the treatment of ...
EU health regulator clears use of AI tool in fatty liver disease trials
A European Medicines Agency committee, on Thursday, accepted the use of an artificial intelligence (AI) tool called AIM-NASH ...
EL PAÍS English4d
The polypill is back: Should everyone over 50 be given a pill to prevent cardiovascular disease?
A new article proposes offering citizens over 50 a combined medication that includes a cocktail of blood pressure-lowering ...
Roche To Share Latest Scientific Advancements From Its Neuromuscular Portfolio At Muscular Dystrophy Association (MDA) 2025 Conference
New Evrysdi five-year data from the SUNFISH study showed continued stabilisation of motor function in a broad population of ind ...